市场调查报告书
商品编码
1439330
输尿管镜 - 全球市场回顾、竞争格局、市场预测 (2030)Ureteroscope - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球输尿管镜市场规模预计到2023年将达到9亿美元,到2030年将达到12.4亿美元,2024-2030年预测期间复合年增长率为5.49%。输尿管镜检查的需求增加可能是由于肥胖负担增加导致尿路结石或肾结石盛行率增加,而肥胖是肾结石形成的危险因子。此外,久坐的生活方式、产品设计的创新和新产品的推出也是促进市场成长的因素。
输尿管镜市场动态
近年来,由于全球泌尿道结石盛行率不断上升,输尿管镜检查的发展势头强劲。根据欧洲泌尿外科协会European Association of Urology(2019)的数据,尿路结石的盛行率从 1% 到 20% 不等,生活水准高的国家,如加拿大、瑞典和美国,肾结石的盛行率较低结石,相当高(超过10%)。
此外,久坐的生活方式增加,例如过量饮酒和减少液体摄取量,也可能导致肾结石的形成。此外,由于不良饮食习惯和缺乏运动等久坐的生活方式,肥胖是肾结石形成的高风险因素,肥胖负担的增加也可能促进输尿管镜市场的成长。根据世界卫生组织(WHO)(2022)的数据,2016年全球肥胖人数约6.5亿。此外,各种研究(包括Poore W.等人于2020年在NCBI发表的《肥胖及其对肾结石形成的影响》 "Obesity and Its Impact on Kidney Stone Formation" )表明,肥胖者更容易形成尿酸结石和草酸钙结石。这种情况经常发生。
因此,上述因素预计将促进全球输尿管镜市场的成长。
然而,能够在医疗环境中使用输尿管镜的熟练工人数量有限以及输尿管镜的高昂成本预计将对输尿管镜市场的成长构成挑战。
输尿管镜市场区隔分析
在输尿管镜产品领域,输尿管软镜预计在预测期内将占据最大的市场份额。这是因为输尿管软镜广泛应用于各种肾结石和输尿管结石的治疗。此外,由于与半刚性输尿管镜相比,柔性输尿管镜是最新一代设备,因此它们对患者造成的疼痛和不适较少,且不太可能造成伤害。输尿管软镜相对于半硬性输尿管镜的优势将使患者需求转向输尿管软镜,扩大输尿管软镜市场。此外,医院输尿管软镜的增加也是输尿管软镜市场的驱动因素。例如,输尿管软镜与雷射碎石术一起被泌尿科医生广泛应用于几乎所有医院,以更好地治疗泌尿系结石,成功率高,併发症率低。此外,逆行性输尿管软镜(RFU)在诊断尿路上皮癌方面具有较高的敏感性。
因此,上述因素可望带动输尿管软镜市场的发展。
预计北美将主导整个输尿管镜市场
在所有地区中,北美预计将主导整个输尿管镜市场。这一优势得益于该地区有利的报销方案、先进的医疗基础设施以及上尿路结石疾病手术和医疗管理的详细指南,预计将推动输尿管镜市场的发展。
此外,美国上泌尿道尿路上皮癌(UTUC)病例数的增加也是输尿管镜检查使用增加的原因之一。例如,根据美国疾病管制与预防中心 (CDC) 的数据 (2020),美国约有 17,500 名女性和 56,000 名男性患有膀胱癌。此外,根据加拿大癌症协会 Canadian cancer society (2020) 的数据,2020 年约有 12,200 名加拿大人患有膀胱癌。
此外,该地区新产品的推出可能会推动该地区输尿管镜市场的发展。例如,2019 年,多尼尔医疗科技Dornier Medtech宣布在美国推出并立即上市新型 AXIS 一次性数位输尿管软镜。因此,这些因素预计将在预测期内对输尿管镜市场做出贡献。
本报告提供了全球输尿管镜市场的研究和分析,包括市场规模和预测、驱动因素和挑战、公司和产品概况。
Ureteroscope Market By Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Urothelium Cancer, Urinary Strictures), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography, is expected to grow at a constant CAGR forecast till 2030 due to the growing prevalence of urolithiasis among the population and technological advancement in the product portfolio.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030. The rise in demand for ureteroscope can be due to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for development of kidney stones. In addition, sedentary lifestyle, innovation in product design, and new product launches among others are the factors responsible for the global market growth of ureteroscope.
Ureteroscope Market Dynamics:
Ureteroscope is gaining momentum in recent years owing to the rising prevalence of urolithiasis across the globe. According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).
Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, less consumption of water could also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a high-risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities could also contribute to the ureteroscope market growth. As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies (one of them being "Obesity and Its Impact on Kidney Stone Formation" by Poore W. et al., published in the NCBI in the year 2020) obese people develop more uric acid stones and calcium oxalate stones.
Thus, the aforementioned factors are anticipated to augment the global ureteroscope market growth.
However, certain factors such as the limited availability of a skilled workforce to utilise the device in medical setup and the high cost of ureteroscope devices are expected to pose a challenge to the ureteroscope market growth.
Ureteroscope Market Segment Analysis:
Ureteroscope Market Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Ureter Transitional Cell Cancer, Urinary Strictures), By End User (Hospitals, Ambulatory Surgical Centers and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Ureteroscope product segment, the flexible ureteroscope is anticipated to hold the largest market share during the forecasted period. This is due to the wide use of the flexible ureteroscope for the treatment of various kidney and ureter stones. Also, flexible ureteroscopy is a latest generation of device when compared to semi rigid ureteroscopy and thus they causes minimum pain and discomfort to the patient with low chances of injury. The advantages of flexible ureteroscopy over semi-rigid ureteroscopy will shift the demand of patients towards flexible ureteroscopy thereby increasing the market for flexible ureteroscope. Moreover, increase in flexible ureteroscopy in hospitals is also a factor driving the market for flexible ureteroscope. For instance, flexible ureteroscope are widely used along with laser lithotripsy in nearly all hospitals by the urologists for better management of urolithiasis with high success rate and low complication rate. Moreover, retrograde flexible ureteroscopy (RFU) has high sensitivity for the diagnosis of urinary tract urothelial carcinomas.
Thus, the above-mentioned factors are expected to drive the flexible ureteroscope market.
North America is expected to dominate the overall Ureteroscope Market:
Among all the regions, North America is expected to dominate the overall ureteroscope market. This domination is owing to the favourable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.
Further, in the United States the rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for increase in usage of ureteroscope. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US. Moreover, according to the Canadian cancer society 2020 data, there were around 12,200 Canadians suffered from bladder cancer in the year 2020.
In addition, the launch of new products in the region is likely to propel the market for ureteroscope in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US. Thus, these factors are projected to contribute to the ureteroscope market during the forecasted period.
Additionally, the Asia-pacific region has future potential for the ureteroscope market. This is because of the rising number of kidney and bladder cancer in the region. Also, the growing cases of urolithiasis are factors expected to promote the growth of ureteroscope in the region. For instance, as per the GLOBOCAN 2022 data, there were approximately 21,096 and 16,861 cases of bladder and kidney respectively in India in the year 2020. Moreover, improving healthcare infrastructure, growing disposable income in the region could also boost the ureteroscope market.
Ureteroscope Market Key Players:
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Recent Developmental Activities in the Ureteroscope Market:
In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
Key Takeaways from the Ureteroscope Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Ureteroscope market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Ureteroscope Market.
Various opportunities available for the other competitor in the Ureteroscope Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Ureteroscope market growth in the coming future?
Target Audience Who Can Be Benefited from the Ureteroscope Market Report Study
Ureteroscope providers
Research organizations and consulting companies
Ureteroscope-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Ureteroscope
Various End-users who want to know more about the Ureteroscope Market and latest technological developments in the Ureteroscope market.
Frequently Asked Questions for the Ureteroscope Market:
Ureteroscope is a small flexible telescope that is inserted into the bladder and ureter to diagnose and treat a variety of problems associated with the urinary tract.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030.
The major factors driving the demand for Ureteroscope are the rising cases of urolithiasis, increase in demand for minimally invasive procedures for kidney stone management, rising sedentary lifestyle, among others. In addition, new product launch and technological advancement in the ureteroscope product portfolio is also expected to augment the market.
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Among all the regions, North America is expected to dominate the overall ureteroscope market during the forecasted period, 2024-2030. This domination is owing to the favorable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.